Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- JNJ-89495120Phase 21 trial
Johnson & Johnson (Janssen) · Depressive Disorder, Major
- JNJ-90014496Phase 21 trial
Johnson & Johnson (Janssen) · Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse
- JR-171lepunafuspPhase 21 trial
JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis I
- JR-441posnafuspPhase 21 trial
JCR Pharmaceuticals Co., Ltd. · Mucopolysaccharidosis III-A
- JS111AP-L1898Phase 21 trial
Suzhou Junjing BioSciences Co., Ltd. · NSCLC
- JT002Phase 21 trial
Shanghai JunTop Biosciences Co., LTD · Seasonal Allergic Rhinitis
- JTM201Phase 21 trial
Jetema USA Inc. · Glabellar Lines
- JTT-861Phase 21 trial
Shionogi Inc. · Chronic Heart Failure
- JUV-161Phase 21 trial
Juvena Therapeutics · Healthy Volunteers
- JYP0015Phase 21 trial
Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)
- KAI-7535Phase 21 trial
Kailera · Obesity, Overweight
- KAN-101Phase 21 trial
Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA · Celiac Disease, Coeliac Disease
- KAND567FractalkinePhase 21 trial
Novakand Pharma AB · Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
- KB304Phase 21 trial
Krystal Biotech, Inc. · Wrinkles in Decolletage, Pigmentation, Décolleté Wrinkles
- KB801Phase 21 trial
Krystal Biotech, Inc. · Neurotrophic Keratitis
- KBP-336Phase 21 trial
KeyBioscience AG · Osteoarthritis in the Knee, Obesity
- KC1086Phase 21 trial
Beijing Konruns Pharmaceutical Co., Ltd. · HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer
- KDT-3594Phase 21 trial
Kissei Pharmaceutical Co., Ltd. · Parkinson Disease
- KELI-101Phase 21 trial
Kelifarma · Preemptive Therapy of Patients At Risk for Acute Kidney Injury Following Cardiac Surgery
- KeynatinibTL007Phase 21 trial
Medolution Ltd. · Non-Small Cell Lung Cancer With EGFR Mutation, Brain Metastases
- KH617Phase 21 trial
Sichuan Honghe Biotechnology Co., Ltd. · Recurrent Glioblastoma
- KH631Phase 21 trial
Chengdu Origen Biotechnology Co., Ltd. · Age-Related Macular Degeneration
- KH658Phase 21 trial
Chengdu Origen Biotechnology Co., Ltd. · Age-related Macular Degeneration
- KHN922Phase 21 trial
Chengdu Kanghong Biotech Co., Ltd. · Advanced Solid Tumors Cancer
- KIO-104Phase 21 trial
Kiora Pharmaceuticals, Inc. · Macular Edema
- KIO-301Phase 21 trial
Kiora Pharmaceuticals, Inc. · Retinitis Pigmentosa
- KIT2014Phase 21 trial
Kither Biotech Srl · Chronic Obstructive Pulmonary Disease (COPD)
- KITE-363Phase 21 trial
Gilead Sciences · Relapsed and/or Refractory B-cell Lymphoma
- KJ101Phase 21 trial
Shanghai Bao Pharmaceuticals Co., Ltd. · Burn, Burn Wounds - Partial Thickness (2nd Degree)
- KJ103Phase 21 trial
Shanghai Bao Pharmaceuticals Co., Ltd. · Anti-Glomerular Basement Membrane Disease
- KK2430Phase 21 trial
Kyowa Kirin Co., Ltd. · Hematologic Neoplasms
- KK8123Phase 21 trial
Kyowa Kirin Co., Ltd. · X-linked Hypophosphatemia
- KL590586Phase 21 trial
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Advanced Solid Tumor
- KN035Phase 21 trial
3D Medicines (Sichuan) Co., Ltd. · Solid Tumor
- KN713Phase 21 trial
New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- KP104Phase 21 trial
Kira Pharmacenticals (US), LLC. · Glomerulonephritis
- KQB198Phase 21 trial
Kumquat Biosciences Inc. · GIST - Gastrointestinal Stromal Tumor, GIST, GIST Metastatic Cancer
- KRRO-121Phase 21 trial
Korro Bio, Inc. · Urea Cycle Disorders, Inborn, Urea Cycle Disorders, Ornithine Transcarbamylase (OTC) Deficiency
- KUS121Phase 21 trial
Kyoto Drug Discovery and Development Co., Ltd. · Central Retinal Artery Occlusion
- KVA12123Phase 21 trial
Kineta Inc. · Cancer, Solid Tumor, Melanoma
- KY-0301Phase 21 trial
Novatim Immune Therapeutics (Zhejiang) Co., Ltd. · Solid Tumors
- Kylo 0603Phase 21 trial
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Metabolic Dysfunction-Associated Steatoic Liver Disease
- Kylo-11Phase 21 trial
Kylonova (Xiamen) Biopharma co., LTD. · Lipoprotein Disorder
- KYN-5356Phase 21 trial
Kynexis B.V. · Cognitive Impairment Associated With Schizophrenia (CIAS)
- L608Phase 21 trial
Pharmosa Biopharm Inc. · Systemic Sclerosis
- lacutamabIPH4102Phase 21 trial
Innate Pharma · Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome
- LAD191Phase 21 trial
Almirall, S.A. · Hidradenitis Suppurativa
- LAD328Phase 21 trial
Almirall, S.A. · Hidradenitis Suppurativa
- LAD603Phase 21 trial
Almirall, S.A. · Alopecia Areata
- LAT010Phase 21 trial
Latticon Antibody Therapeutics, Inc · Advanced Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.